Tag: Heather Bresch

January 11, 2017

Trump Sends Pharmaceutical Stocks Tumbling

US President-elect Donald Trump did not mince words on Wednesday morning during his first press conference since November, which plummeted...
December 26, 2016

Top Pharmaceutical News Stories of 2016

2016 saw countless pharmaceutical companies taken to task for price gouging. Close to the end of the year, a related...
October 17, 2016

After $465 Million Payout, Mylan Still Faces Shareholder Lawsuit

As we predicted several weeks ago, Mylan isn’t out of hot water yet: the embattled pharmaceutical giant now faces a...
October 10, 2016

Mylan Reaches $465 Million Settlement with Department of Justice

Mylan announced on October 7, 2016, that they will pay a $465 million settlement to the US federal government, clearing...
October 4, 2016

3 Top Performing Pharmaceutical Stocks of 2016

Despite some industry hurdles, several pharmaceutical companies have managed to come out ahead—and so have their shareholders.
September 26, 2016

From the EpiPen to Naloxone: Mylan May Not Be Out of Hot Water Yet

Is naloxone the next drug that will bring a pharmaceutical executive before Congress? The life-saving medication can now cost $2,000...
August 26, 2016

Mylan Ups EpiPen Price, Banks Maintain "Buy" Ratings

Despite the uproar on Mylan (NASDAQ:MYL) increasing its EpiPen® price, Goldman Sachs and Wells Fargo have maintained their positive ratings.